CEL-SCI Corporation
CVMHealthcare|Biotechnology|US
$1.45
+0.08 (+5.84%)
DCF Value
$0.21
Tangible Book / Share
$0.90
Cash / Share
$0.54
Clinical Trials (3)
| Trial | Conditions | Phase | Status | Enrollment | Design | Drug |
|---|---|---|---|---|---|---|
| NCT01265849 Efficacy and Safety Study of Leukocyte Interleukin,Injection (LI) to Treat Cancer of the Oral Cavity | Squamous Cell Carcinoma of the Oral Cavity, Squamous Cell Carcinoma of the Soft Palate | P3 | Completed | 928 | RCT, Open-label | LI, Cyclophosphamide, Indomethacin, Cisplatin |
| NCT02115919 Safety Study of Multikine in the Treatment of Perianal Warts | Condyloma | P1 | Terminated | 4 | Open-label | Leukocyte Interleukin, Injection 200IU, Leukocyte Interleukin, injection 400IU |
| NCT03038828 Study of Leukocyte Interleukin, Injection for Treatment of Perianal Warts | Perianal Warts | P1 | Terminated | 8 | Open-label | Leukocyte Interleukin, Injection |